BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 24605938)

  • 1. Molecular mechanisms of TNFR-associated factor 6 (TRAF6) utilization by the oncogenic viral mimic of CD40, latent membrane protein 1 (LMP1).
    Arcipowski KM; Stunz LL; Graham JP; Kraus ZJ; Vanden Bush TJ; Bishop GA
    J Biol Chem; 2011 Mar; 286(12):9948-55. PubMed ID: 21262968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A c-Myc and surface CD19 signaling amplification loop promotes B cell lymphoma development and progression in mice.
    Poe JC; Minard-Colin V; Kountikov EI; Haas KM; Tedder TF
    J Immunol; 2012 Sep; 189(5):2318-25. PubMed ID: 22826319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of Vav-promoter-driven overexpression of BCLX and BFL1 on lymphocyte survival and B cell lymphomagenesis.
    Tuzlak S; Haschka MD; Mokina AM; Rülicke T; Cory S; Labi V; Villunger A
    FEBS J; 2018 Apr; 285(8):1403-1418. PubMed ID: 29498802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights about MYC and Apoptosis in B-Lymphomagenesis: An Update from Murine Models.
    Vecchio E; Fiume G; Correnti S; Romano S; Iaccino E; Mimmi S; Maisano D; Nisticò N; Quinto I
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32549409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-Circuiting Gene Regulatory Networks: Origins of B Cell Lymphoma.
    Koues OI; Oltz EM; Payton JE
    Trends Genet; 2015 Dec; 31(12):720-731. PubMed ID: 26604030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.
    Ma SD; Xu X; Plowshay J; Ranheim EA; Burlingham WJ; Jensen JL; Asimakopoulos F; Tang W; Gulley ML; Cesarman E; Gumperz JE; Kenney SC
    J Clin Invest; 2015 Jan; 125(1):304-15. PubMed ID: 25485679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenesis by Moloney murine leukemia virus.
    Tsichlis PN
    Anticancer Res; 1987; 7(2):171-80. PubMed ID: 3592629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role and mechanism of PIM family in the immune microenvironment of diffuse large B cell lymphoma.
    Wang C; Chen Q; Luo H; Chen R
    World J Surg Oncol; 2023 Mar; 21(1):76. PubMed ID: 36871027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA helicase DHX15 decreases cell apoptosis by NF-κB signaling pathway in Burkitt lymphoma.
    Chen Y; Chen X; Pan L; Huang Y; Cai Y; Li J; Li Y; Wang S
    Cancer Cell Int; 2022 Feb; 22(1):92. PubMed ID: 35193582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eμ-TCL1xMyc: A Novel Mouse Model for Concurrent CLL and B-Cell Lymphoma.
    Lucas F; Rogers KA; Harrington BK; Pan A; Yu L; Breitbach J; Bundschuh R; Goettl VM; Hing ZA; Kanga P; Mantel R; Sampath D; Smith LL; Wasmuth R; White DK; Yan P; Byrd JC; Lapalombella R; Woyach JA
    Clin Cancer Res; 2019 Oct; 25(20):6260-6273. PubMed ID: 31296529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr Functional Mimicry: Pathogenicity of Oncogenic Latent Membrane Protein-1 in Systemic Lupus Erythematosus and Autoimmunity.
    Munroe ME; Anderson JR; Gross TF; Stunz LL; Bishop GA; James JA
    Front Immunol; 2020; 11():606936. PubMed ID: 33613527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-kappaB/STAT3/PI3K signaling crosstalk in iMyc E mu B lymphoma.
    Han SS; Yun H; Son DJ; Tompkins VS; Peng L; Chung ST; Kim JS; Park ES; Janz S
    Mol Cancer; 2010 Apr; 9():97. PubMed ID: 20433747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Latent Membrane Protein 1 (LMP1).
    Kieser A; Sterz KR
    Curr Top Microbiol Immunol; 2015; 391():119-49. PubMed ID: 26428373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons from Using Genetically Engineered Mouse Models of MYC-Induced Lymphoma.
    Winkler R; Piskor EM; Kosan C
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new model of LMP1-MYC interaction in B cell lymphoma.
    Ontiveros EP; Halwani A; Stunz LL; Kamberos N; Olivier AK; Janz S; Bishop GA
    Leuk Lymphoma; 2014 Dec; 55(12):2917-23. PubMed ID: 24605938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latent membrane proteins from EBV differentially target cellular pathways to accelerate MYC-induced lymphomagenesis.
    Ikeda M; Hayes CK; Schaller SJ; Longnecker R
    Blood Adv; 2022 Jul; 6(14):4283-4296. PubMed ID: 35605249
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.